Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Molcure, a Japan-based AI-driven drug discovery and developing company backed by University of Tokyo affiliate University of Tokyo Edge Capital (UTEC), has raised $7.2m in series C funding from GMO Venture Partners, Japan Post Capital, Strive and SBI Investment, respective vehicles for internet company GMO, postal service Japan Post, digital media group Gree and financial services firm SBI, in addition to pharmaceutical firm Nippon Chemiphar and VC firm Jafco. Molcure raised $2.5m from GMO VenturePartners, Nippon Chemiphar and insurer Dai-ichi Life…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
